Di Nunno Vincenzo, Gatto Lidia, Aprile Marta, Bartolini Stefania, Tosoni Alicia, Franceschi Enrico
Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Neurooncol Pract. 2024 May 11;11(5):546-555. doi: 10.1093/nop/npae045. eCollection 2024 Oct.
Within socioeconomic variables, economic income has been associated with the prognosis of patients with glioblastoma. However, studies investigating this issue provided conflicting results.
We carried out a systematic review and meta-analysis of studies investigating the correlation between economic income and survival in patients with glioblastoma. The inverse variance technique for hazard ratio (HR) assessment has been employed in reporting the random effect model.
We included 12 studies for a total of 143 303 GBM patients (67 463 with high economic income, and 25 679 with low economic income). In the overall analysis, lower economic income resulted in poorer survival (pooled HR 1.09, 95% CI: 1.02-1.17, I = 64%). Variables like the type of Health Care System (public, private, or mixed) and the time in which patients have been treated (pre or post-EORTC-NCIC trial 22981/26981, CE.3 protocol advent) did not modify survival on pooled analysis.
Economic conditions and income influence the prognosis of patients with glioblastoma. A better understanding of the modifiable barriers leading to treatment disparities in more disadvantaged patients is warranted to make equal oncological care.
在社会经济变量中,经济收入与胶质母细胞瘤患者的预后相关。然而,调查此问题的研究结果相互矛盾。
我们对调查经济收入与胶质母细胞瘤患者生存率之间相关性的研究进行了系统评价和荟萃分析。在报告随机效应模型时采用了风险比(HR)评估的逆方差技术。
我们纳入了12项研究,共143303例胶质母细胞瘤患者(67463例经济收入高,25679例经济收入低)。在总体分析中,较低的经济收入导致较差的生存率(合并HR 1.09,95%CI:1.02-1.17,I=64%)。医疗保健系统类型(公立、私立或混合)以及患者接受治疗的时间(欧洲癌症研究与治疗组织-加拿大国家癌症研究所试验22981/26981之前或之后,CE.3方案出现之前或之后)等变量在汇总分析中并未改变生存率。
经济状况和收入影响胶质母细胞瘤患者的预后。有必要更好地了解导致处境更为不利患者治疗差异的可改变障碍,以实现平等的肿瘤护理。